Mandin, Rita Bea May C.
HRN: 21-32-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CO-AMOXICLAV 625MG (TAB)
05/07/2022
05/14/2022
PO
625
Q12H
Non-institutional Delivery
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes